Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Does Colonoscopy as a First Screening Test Still Make Sense?-Counterpoint.
Dig Dis Sci
December 2024
Department of Internal Medicine, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei, Taiwan.
Colonoscopy has been widely regarded as the gold standard for its high diagnostic accuracy and preventive potential. However, its invasive nature, high cost, and suboptimal participation rates limit its utility at the population level. Non-invasive screening tests, notably the fecal immunochemical test (FIT) and multitarget stool DNA tests, present promising alternatives that may improve screening participation and reduce barriers to participation.
View Article and Find Full Text PDFInteractions between a pathogenic Blastocystis subtype and gut microbiota: in vitro and in vivo studies.
Microbiome
March 2019
Laboratory of Molecular and Cellular Parasitology, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, Singapore, 117545, Singapore.
Background: Blastocystis is a common gut eukaryote detected in humans and animals. It has been associated with gastrointestinal disease in the past although recent metagenomic studies also suggest that it is a member of normal microbiota. This study investigates interactions between pathogenic human isolates belonging to Blastocystis subtype 7 (ST7) and bacterial representatives of the gut microbiota.
View Article and Find Full Text PDFCounterpoint: Should all stools be screened for Shiga toxin-producing Escherichia coli?
J Clin Microbiol
July 2011
Department of Clinical Pathology, SUNY Upstate Medical University, Syracuse, New York 13210, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!